Showing results (131-140 of 451) with videos related to
Sort By:
Pageof 46
Rheumatology (Oxford, England)|March 21, 2021
ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologiesMichael Hughes, Bashar Kahaleh, Christopher P Denton, et al.BMJ Case Reports|January 6, 2019
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiencyCorrado Campochiaro, Sirin Atay, Kristina E N Clark, et al.Rheumatology (Oxford, England)|April 21, 2011
Internal anal sphincter atrophy in patients with systemic sclerosisNora M Thoua, Alexis Schizas, Alastair Forbes, et al.The American Journal of Pathology|May 10, 2002
Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosisBing Zheng, Zhaoping Zhang, Carol M Black, et al.Therapeutic Advances in Respiratory Disease|September 28, 2025
How do doctors and patients communicate about the treatment of systemic sclerosis-associated interstitial lung disease? A plain language summary of publicationMasataka Kuwana, Aiko Saito, Sue Farrington, et al.Rheumatology (Oxford, England)|May 17, 2024
Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertensionDaniel S Knight, Ruta Virsinskaite, Nina Karia, et al.European Heart Journal. Cardiovascular Imaging|July 1, 2022
Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance studyDaniel S Knight, Nina Karia, Alice R Cole, et al.Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.Journal of Cell Communication and Signaling|July 20, 2011
Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglinAlan M Holmes, Markella Ponticos, Xu Shi-Wen, et al.ACR Open Rheumatology|January 23, 2025
Impact of Scleroderma-Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial of Tocilizumab in SclerodermaBasmah Al Dulaijan, Suiyuan Huang, Celia J F Lin, et al.Pageof 46